Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer.
about
Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Breast cancer stem cells in HE ...... t HER2-negative breast cancer.
@en
Breast cancer stem cells in HE ...... t HER2-negative breast cancer.
@nl
type
label
Breast cancer stem cells in HE ...... t HER2-negative breast cancer.
@en
Breast cancer stem cells in HE ...... t HER2-negative breast cancer.
@nl
prefLabel
Breast cancer stem cells in HE ...... t HER2-negative breast cancer.
@en
Breast cancer stem cells in HE ...... t HER2-negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Breast cancer stem cells in HE ...... t HER2-negative breast cancer.
@en
P2093
Hyang Suk Choi
Hyesil Seol
Hyun-Ah Kim
In Chul Park
Jae-Sung Kim
Ji-Hyun Kim
Jin Kyung Lee
Kwang Il Kim
Min-Ki Seong
Woo Chul Noh
P2860
P304
P356
10.18632/ONCOTARGET.23528
P407
P577
2017-12-20T00:00:00Z